Early and prolonged response to pazopanib in a patient with multiple metastases from renal cell carcinoma: a case report.
Tumori
; 100(3): e83-6, 2014.
Article
em En
| MEDLINE
| ID: mdl-25076257
AIMS AND BACKGROUND: In recent years, targeted agents have replaced cytokine therapy as the standard of care for patients with metastatic renal cell carcinoma. METHODS AND STUDY DESIGN: We report a patient with multiple metastases from renal cell carcinoma treated with cytoreductive surgery and pazopanib. RESULTS AND CONCLUSIONS: The treatment resulted in an early and prolonged response, without toxicity.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pirimidinas
/
Sulfonamidas
/
Carcinoma de Células Renais
/
Inibidores da Angiogênese
/
Neoplasias Renais
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article